Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany: Real-world evidence on prevalence, disease combinations, care

被引:0
|
作者
Riemekasten, Gabriela [1 ]
Schmelz, Renate [2 ]
Schaekel, Knut [3 ]
Thaci, Diamant [4 ]
Schreiber, Stefan [5 ,6 ]
Roecken, Marit [7 ]
Bartz, Holger [7 ]
Ploner, Tina [8 ]
Liao, Ximing [8 ]
Weber, Valeria [9 ]
Manz, Karina C. [9 ]
Burkhardt, Harald [10 ]
Leipe, Jan [11 ]
机构
[1] Univ klinikum Schleswig Holstein, Klin Rheumatol & Klin Immunol, Lubeck, Germany
[2] Univ klinikum Carl Gustav Carus Dresden, Med Klin & Poliklin 1, Fetscherstr 74, D-01307 Dresden, Germany
[3] Univ klinikum Heidelberg, IZEH Interdisziplinares Zent chron entzundl Erkran, Heidelberg, Germany
[4] Univ Lubeck, Inst & Exzellenzzentrum Entzundungs Med, Lubeck, Germany
[5] Univ klinikum Schleswig Holstein, Klin Innere Med 1, Campus Kiel, Kiel, Germany
[6] Univ klinikum Schleswig Holstein, Inst Klin Molekularbiol, Campus Kiel, Kiel, Germany
[7] Janssen Cilag GmbH, Neuss, Germany
[8] InGef Inst Angew Gesundheitsforschung Berlin GmbH, Berlin, Germany
[9] IGES Inst GmbH, Berlin, Germany
[10] Univ klinikum Frankfurt, Goethe Univ Frankfurt Main, Fraunhofer Inst Translationale Med & Pharmakol ITM, Med Klin II Rheumatol, Frankfurt, Germany
[11] Univ klinikum Mannheim, V Med Klin, Sekt Rheumatol, Mannheim, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2024年 / 83卷 / 07期
关键词
Immune-mediated inflammatory diseases; Health insurances accounting data; Retrospective cross-sectional analysis; Multidisciplinary approach; Efficiency of care; PSORIATIC-ARTHRITIS; BOWEL-DISEASE;
D O I
10.1007/s00393-023-01459-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic inflammatory diseases (immune-mediated inflammatory diseases, IMID) can overlap or occur simultaneously due to clinical similarities. The resulting utilization of heathcare structures has not yet been investigated across disciplines but is of potential importance for optimizing the treatment of patients with IMID.<br />Aim of the work: Analysis of epidemiological data including utilization of care services in patients with selected IMIDs: psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA), ankylosing spondylitis, ulcerative colitis, Crohn's disease and connective tissue disease.<br />Material and methods: In a retrospective cross-sectional analysis based on health insurances accounting data with a sample of approximately 4 million insured persons, the prevalence of the abovementioned IMID and the frequency of IMID combinations were analyzed based on documented diagnoses (ICD-10 GM). The frequency of hospitalizations and utilization of outpatient physician contacts was recorded in predefined specialist disciplines (general medicine, dermatology, gastroenterology, rheumatology) and compared with an age-adjusted and gender-adjusted reference population.<br />Results: A total of 188,440 patients had at least 1 of the IMID diagnoses analyzed (4.7%), with an age peak of 61-70 years. The highest prevalence was observed for psoriasis (1.85%), followed by rheumatoid arthritis (1.38%). Combinations with at least one other IMID were relatively common (29%), with this being most common in patients with psoriatic arthritis (82.9%, of which 68.2% had psoriasis), followed by ankylosing spondylitis (27.5%) and Crohn's disease (21.6%). Compared to the reference population, patients with IMID were hospitalized more often and more frequently utilized the outpatient disciplines.<br />Discussion: The study results describe that IMIDs occur in combination and that the patients make comparatively more use of care structures of different disciplines. A multidisciplinary approach could increase the efficiency of care; an evaluation is still pending.
引用
收藏
页码:578 / 586
页数:9
相关论文
共 50 条
  • [31] Epidemiology and health care utilization of patients suffering from Huntington's disease in Germany: real world evidence based on German claims data
    Ohlmeier, Christoph
    Saum, Kai-Uwe
    Galetzka, Wolfgang
    Beier, Dominik
    Gothe, Holger
    BMC NEUROLOGY, 2019, 19 (01)
  • [32] Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities
    Islam, Prioty
    Mato, Anthony R.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (04) : 254 - 260
  • [33] Is it time to use real-world data from primary care in Alzheimer's disease?
    Ponjoan, Anna
    Garre-Olmo, Josep
    Blanch, Jordi
    Fages, Ester
    Alves-Cabratosa, Lia
    Marti-Lluch, Ruth
    Comas-Cufi, Marc
    Parramon, Didac
    Garcia-Gil, Maria
    Ramos, Rafel
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [34] Medical Information Mart for Intensive Care: A Foundation for the Fusion of Artificial Intelligence and Real-World Data
    Rogers, Paul
    Wang, Dong
    Lu, Zhiyuan
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2021, 4
  • [35] Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
    Folkerts, Kerstin
    Millier, Aurelie
    Smela, Beata
    Olewinska, Elzbieta
    Schmedt, Niklas
    Mernagh, Paul
    Kovesdy, Csaba P.
    JOURNAL OF NEPHROLOGY, 2023, 36 (04) : 1135 - 1167
  • [36] Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
    Kerstin Folkerts
    Aurelie Millier
    Beata Smela
    Elzbieta Olewinska
    Niklas Schmedt
    Paul Mernagh
    Csaba P. Kovesdy
    Journal of Nephrology, 2023, 36 : 1135 - 1167
  • [37] Differential response to roflumilast in patients with chronic obstructive pulmonary disease: real-world evidence
    Lee, Hyun Woo
    Sun, Jiyu
    Lee, Hyo-Jin
    Lee, Jung-Kyu
    Park, Tae Yeon
    Heo, Eun Young
    Rhee, Chin Kook
    Kim, Deog Kyeom
    JOURNAL OF THORACIC DISEASE, 2024, 16 (02) : 1338 - 1349
  • [38] Administrative Prevalence and Health Care Situation of Dementia Patients in Acute Care Hospitals: An Epidemiological Health Care Study Based on Claims Data of Insured Persons in Saxony
    Motzek, Tom
    Werblow, Andreas
    Schmitt, Jochen
    Marquardt, Gesine
    GESUNDHEITSWESEN, 2019, 81 (12) : 1022 - 1028
  • [39] Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study
    Martinez-Lopez-de-Castro, N.
    Alvarez-Payero, M.
    Samartin-Ucha, M.
    Martinez-Reglero, C.
    Martin-Vila, A.
    Rodriguez-Rodriguez, M.
    Pineiro-Corrales, G.
    Maceiras-Pan, J. F.
    Melero-Gonzalez, R. B.
    Pego-Reigosa, J. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : 736 - 745
  • [40] Overcoming challenges in real-world evidence generation: An example from an Adult Medical Care Coordination program
    Savitz, Samuel T.
    Lampman, Michelle A.
    Inselman, Shealeigh A.
    Dholakia, Ruchita
    Hunt, Vicki L.
    Mattson, Angela B.
    Stroebel, Robert J.
    Mccabe, Pamela J.
    Witwer, Stephanie G.
    Borah, Bijan J.
    LEARNING HEALTH SYSTEMS, 2024, 8